China FDA Calls for Comments on Key Policy Proposals

Published date15 May 2017
Law FirmRopes & Gray LLP
AuthorKatherine Wang
Subject MatterMedical Devices,China,Prescription Drugs,Comment Period,China FDA,Pharmaceutical Industry

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT